Skip to main content
Loading Events
December 3

Low birthweight and preterm infant feeding: Progress, challenges, and evaluation approach for lactation support and human milk fortification

Katherine Semrau.
Location
Building 1, Room 1208
665 Huntington Ave.
Boston, Massachusetts 02115

Event Time

1:00 pm – 2:00 pm

Join the Department of Global Health and Population for this Brown Bag Seminar featuring Katherine Semrau, director of the BetterBirth Program and deputy director at Ariadne Labs and associate professor at Harvard Medical School and Harvard T.H. Chan School of Public Health. Please note that an HUID is required to attend this in-person seminar.

Seminar description

Small vulnerable newborns (SVNs), those born too soon or too small, represent 1 in every 4 live births and account for >55% of newborn deaths—of every 2 newborn deaths, 1 is among an SVN. Moreover, 2 in 3 babies can be saved with proven low-cost interventions. These interventions are particularly critical for SVNs, but coverage remains inadequate. In 2022, the World Health Organization released updated recommendations for the care of preterm and low birthweight infants that highlight proven nutritional interventions, including early and continuous feeding of mother’s own milk, provision of immediate and continuous KMC, and the importance of family involvement and support, along with quality essential newborn care. Over the past four years, the BetterBirth team at Ariadne Labs has led the LIFT-UP [Low Birthweight & Preterm Infant Feeding Trial & Supportive Care Package] Consortium to use implementation science and randomized controlled trials to address these new guidelines, fill evidence gaps, and advance implementation. This talk will focus on the current progress and challenges faced to improve small vulnerable newborn care and outcomes.

Speaker bio

Katherine Semrau, PhD, MPH, is the director of the BetterBirth Program and deputy director at Ariadne Labs, where she leads efforts to improve the quality of maternal and newborn care through scalable, evidence-based solutions. With over two decades of experience in maternal, newborn, and child health and epidemiology, her work focuses on strengthening frontline care, reducing preventable deaths, and advancing implementation science in global health.

Katherine led the BetterBirth Trial, one of the world’s largest maternal–newborn health studies involving more than 157,000 mother–infant pairs in India, and co-led the Zambia Chlorhexidine Application Trial of over 39,000 births. Her research portfolio includes studies on the WHO Safe Childbirth Checklist, Cesarean Safety Checklist, and facility readiness, as well as initiatives focused on care for low birthweight and preterm infants.

She holds a PhD in epidemiology from Boston University and an MPH in international health and epidemiology from University of Alabama at Birmingham.

Speaker Information

ⓘ Harvard Chan School hosts a diverse array of speakers, invited to share both scholarly research and personal perspectives. They do not speak for the School, and hosting them does not imply endorsement of their views, organizations, or employers.